Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hiraku Endo"'
Autor:
Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Yui Umeyama, Tsukasa Ataka, Haruka Wada, Yumiko Oyamada, Naoki Hyakushima, Ken-ichiro Seino
Publikováno v:
Inflammation and Regeneration, Vol 38, Iss 1, Pp 1-6 (2018)
Abstract Background Cysts of the salivary glands are common lesions that occur in the context of various etiologies. Although the diagnostic importance of cysts in salivary gland diseases has been well studied, molecular mechanisms that control the r
Externí odkaz:
https://doaj.org/article/abc90cc7eed047409e47366fd626b68e
Autor:
Nanumi Han, Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Takuto Kobayashi, Haruka Wada, Keisuke Imafuku, Hiroo Hata, Ken-ichiro Seino
Publikováno v:
Inflammation and Regeneration, Vol 38, Iss 1, Pp 1-5 (2018)
Abstract Background Immunotherapies that target immune-checkpoint molecules such PD-1 have helped to achieve durable responses in melanoma treatment. However, 25% of melanoma patients who showed objective responses to PD-1 blockade develop resistance
Externí odkaz:
https://doaj.org/article/736d7f79a7ae48d2bdd1a3b38348a93c
Autor:
Hideyuki Iwahata, Haruhiro Kondo, Yuriko Iwahata, Hiraku Endo, Haruka Imai, Seido Takae, Nao Suzuki
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 38:152-157
Autor:
Imari Deura, Yuko Nagasawa, Noriyuki Yokomichi, Shiho Kuji, Haruhiro Kondo, Tomo Takenaga, Tatsuru Ohara, Haruka Imai, Hiraku Endo, Ryo Kanamori, Jun Takeuchi, Akiko Tozawa, Nao Suzuki
Publikováno v:
International Journal of Clinical Oncology. 27:25-34
Although the incidence of the various gynecological cancers has been increasing in recent years, long-term survival is now possible for many patients thanks to advances in multimodality treatment. When treating gynecological cancer in adolescent and
Autor:
Tatsuru Ohara, Takamichi Sasaki, Hiraku Endo, Ryo Kanamori, Haruka Imai, Yuko Nagasawa, Hiroyuki Yamanaka, Shinji Hosonuma, Shiho Kuji, Imari Deura, Akiko Tozawa, Nao Suzuki
Publikováno v:
Journal of St. Marianna University. 12:69-75
Autor:
Muhammad Baghdadi, Hiraku Endo, Kozo Ishikawa, Hiroshi Asano, Hisamori Kato, Tatsuya Kato, Yosuke Konno, Naoki Hama, Ryo Otsuka, Daisuke Endo, Haruka Wada, Hidemichi Watari, Atsushi Takano, Nao Suzuki, Tomoyuki Yokose, Yohei Miyagi, Akiko Tozawa, Yataro Daigo, Ken-ichiro Seino
Publikováno v:
International Immunology. 32:175-186
Ovarian cancer is the second-most lethal gynecological malignancy and the seventh-commonest cause of cancer-related death in women around the world. Most of the ovarian cancer patients are diagnosed at advanced stages and suffer from recurrence after
Autor:
Motohiro Chosokabe, Tatsuru Ohara, Haruhiro Kondo, Takamichi Sasaki, Hiroshi Kadono, Reiko Suzuki, Imari Deura, Hiroyuki Yamanaka, Hiraku Endo, Junichi Hasegawa, Nao Suzuki, Takayoshi Nakamura, Junki Koike, Shinji Hosonuma, Shiho Kuji
Publikováno v:
Int Cancer Conf J
This is the case report of primary malignant melanoma (MM) of uterine cervix treated by immune checkpoint inhibitor: the Pembrolizumab. Despite the merge of the novel drugs that has been strikingly improving prognosis of MM, we still struggle treatme
Autor:
Hiraku Endo, Kozo Ishikawa, Haruka Wada, Nanumi Han, Takuto Kobayashi, Ken-ichiro Seino, Muhammad Baghdadi, Hiroo Hata, Keisuke Imafuku
Publikováno v:
Inflammation and Regeneration, Vol 38, Iss 1, Pp 1-5 (2018)
Inflammation and Regeneration
Inflammation and Regeneration
Background Immunotherapies that target immune-checkpoint molecules such PD-1 have helped to achieve durable responses in melanoma treatment. However, 25% of melanoma patients who showed objective responses to PD-1 blockade develop resistance and suff
Autor:
Haruka Wada, Tomoyuki Yokose, Kozo Ishikawa, Hiraku Endo, Haruhiko Nakayama, Nao Suzuki, Hiroyuki Ito, Muhammad Baghdadi, Yosuke Kameda, Yataro Daigo, Yohei Miyagi, Ken-ichiro Seino, Atsushi Takano
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports
Despite recent advances in diagnosis and treatment of lung cancers, the 5-year survival rate remains unsatisfactory, which necessitates the identification of novel factors that associates with disease progression and malignant degree for improving di
Autor:
Imari Deura, H Yamanaka, Miyuki Harada, Norihito Yoshioka, Tatsuru Ohara, Nao Suzuki, Junichi Hasegawa, Akiko Tozawa, Hiraku Endo, Y Osuga, Shiho Kuji
Publikováno v:
ePoster.
Introduction/Background The major fact-finding survey on oncofertility care has not been conducted to date in the field of gynecologic oncology. Therefore, we examined AYA (adolescent and adult) cancer patients with ovarian germ-cell tumors (OGT) on